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Abstract
Laparoscopic hemihepatectomy (LHH) may offer advantages over open hemihepatectomy (OHH) in blood loss, recovery, 
and hospital stay. The aim of this study is to evaluate our recent experience performing hemihepatectomy and compare 
complications and costs up to 90 days following laparoscopic versus open procedures. Retrospective evaluation of patients 
undergoing hemihepatectomy at our center 01/2010–12/2018 was performed. Patient, tumor, and surgical characteristics; 
90-day complications; and costs were analyzed. Inverse probability of treatment weighting (IPTW) was used to balance 
covariates. A total of 141 hemihepatectomies were included: 96 OHH and 45 LHH. While operative times were longer for 
LHH, blood loss and transfusions were less. At 90 days, there were similar rates of liver-specific and surgical complications 
but fewer medical complications following LHH. Medical complications that arose with greater frequency following OHH 
were primarily pulmonary complications and urinary and central venous catheter infections. Complications at 90 days were 
lower following LHH (Clavien–Dindo grade ≥ III OHH 23%, LHH 11%, p = 0.130; Comprehensive Complication Index 
OHH 20.0 ± 16.1, LHH 10.9 ± 14.2, p = 0.001). While operating costs were higher, costs for hospital stay and readmissions 
were lower with LHH. Patients undergoing LHH experience a significant reduction in postoperative medical complications 
and costs, resulting in 90-day cost equity compared with OHH.
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Introduction
The laparoscopic approach to abdominal interventions bet-
ter preserves the integrity and function of the abdominal 
wall and limits exposure and manipulation of abdominal 
viscera, not only leading to improved cosmesis but also 
reduced intraabdominal adhesions and wound and wall 
complications. The loss of manual tissue manipulation and 
control is compensated, at least to some degree, by magni-
fied and direct visualization. In the field of hepatic surgery, 
the results of clinical retrospective studies, meta-analyses, 
and one randomized trial indicate that the aforementioned 
advantages may translate into less perioperative blood loss 
and improved recovery, with decreased postoperative com-
plications and hospital stay [1–4]. For these reasons, the 
laparoscopic approach is now considered standard-of-care 
for the resection of lesions in the left lateral and anterior 
hepatic segments [5].
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In contrast with the aforementioned minor liver resec-
tions, laparoscopic hemihepatectomy (LHH) is still con-
sidered an advanced technique to only be carried out by 
experienced surgeons. While transection may proceed 
across hepatic anatomical planes, these planes remain 
intraparenchymal, highly vascularized, and not recognized 
by standard traction–countertraction maneuvers. As well, 
vascular and biliary structures to one side of the liver have 
to be ligated while preserving structures on the contralat-
eral side, and the liver has to be separated to a certain 
extent from the inferior vena cava, intraoperative injury to 
which can be devastating. Accordingly, a learning curve 
of at least 55 cases for right hemihepatectomy after prior 
experience with minor laparoscopic liver resections has 
been suggested [5, 6].
Aside from increased complexity, cost associated with 
LHH can also be increased, in particular related to the 
use of more expensive surgical instruments and devices 
and longer operative times versus open hemihepatectomy 
(OHH). Cost analyses have determined that operative costs 
may be significantly higher for LHH than for OHH, though 
the increase in upfront cost may be offset, at least in part, 
by improved and less costly postoperative recovery and 
hospital stay [7–10].
The laparoscopic approach to hepatic resection was 
introduced at our center in 2005, and we currently per-
form approximately 75% of our hepatectomies laparo-
scopically. Based on the results of previous studies, we 
hypothesized that fewer complications arise after LHH 
and this difference may translate into not only a shorter 
and less costly postoperative stay but also fewer readmis-
sions and ongoing complications through the end of the 
third postoperative month, whereby the great majority of 
complications following major hepatectomy has occurred 
[11]. The aim of the present study is, therefore, to com-
prehensively evaluate the recent years of our experience 
performing hemihepatectomy and to compare cumulative 
complications and costs measured up to 90 days following 
laparoscopic versus open procedures.
Patients and methods
Study design
This study is a retrospective evaluation of patients under-
going right or left hemihepatectomy at our center between 
January 2010 and December 2018. Exclusion criteria 
included extended hepatectomy, additional biliary or vas-
cular resection, previous portal vein embolization, previous 
hepatectomy (including two-stage hepatectomy), emergency 
hepatectomy, living donor hepatectomy, and synchronous 
multiorgan resection (including bowel resection). Approval 
for the study was obtained from our Institution’s Commit-
tee on Ethics in Medical Research prior to initiating data 
analysis (study number HCB/2018/1179), which waived the 
need for written consent.
Preoperative evaluation
Preoperatively, all patients underwent routine laboratory 
tests and contrast-enhanced multislice abdominal computed 
tomography (CT) and and/or gadolinium-enhanced hepatic 
magnetic resonance imaging (MRI) and were discussed in 
multidisciplinary tumor board. For colorectal liver metas-
tases, preoperative chemotherapy was indicated in cases of 
initially unresectable disease until conversion to resectabil-
ity, borderline resectable disease, and initially resectable 
disease with synchronous presentation. Initial resection of 
the primary tumor was performed in cases with synchronous 
presentation.
Surgical procedures
All surgeons performing LHH had previously performed a 
minimum of 30 laparoscopic liver resections, and all sur-
geons performing both LHH and OHH had extensive experi-
ence performing open hepatic surgery.
Laparoscopic hemihepatectomy
The patient was placed with legs spread and in reverse Tren-
delenburg. Five or six ports were used, with the 12-mm 
camera port placed along the anterior axillary line. Pneu-
moperitoneum was maintained 12–14 mmHg. Following 
mobilization of the right or left liver from its ligamentous 
attachments, intraoperative ultrasound was performed to 
confirm the number and size of the lesion(s). Preparation for 
intermittent Pringle maneuver was performed by encircling 
the hepatic hilum with a tourniquet, which was exteriorized 
through a thoracostomy tube inserted through the abdominal 
wall above the pubic symphysis. An extrahepatic intraglis-
sonian pedicle approach was used to dissect and encircle 
the ipsilateral hepatic artery and portal vein. For left LHH, 
the left lobe was pulled upward, and Arantius’ ligament 
approach was used to encircle the left hepatic vein [12]. For 
right LHH, retrohepatic veins and the hepatocaval ligament 
were divided between titanium or Hem-o-lok® clips, fol-
lowed by dissection and encircling of the right hepatic vein 
to perform liver hanging maneuver. Ischemic delimitation of 
the transection plane was achieved after pedicle clamping, 
and liver transection was performed using a combination of 
LigaSure™ (Medtronic, Minneapolis, Minnesota, USA) and 
Updates in Surgery 
1 3
CUSA® Excel (Valleylab, Boulder, Colorado, USA). Vascu-
lar staplers were used to transect both the hepatic pedicles at 
the level of the hilar plate and hepatic veins and the end of 
parenchymal transection. The surgical specimen was placed 
in an Endo Catch™ Specimen Retrieval Pouch (Medtronic, 
Minneapolis, Minnesota, USA) and removed through a Pfan-
nenstiel incision. The incision was then closed, intraabdomi-
nal hemostasis was checked, and an abdominal drain was 
placed.
Hybrid hemihepatectomy
The hybrid technique was defined as a planned procedure 
that started with liver mobilization and isolation of hepatic 
pedicle through laparoscopic approach. Thereafter, paren-
chymal transection was performed through a 6–8 cm upper 
midline laparotomy, which was also used for specimen 
extraction.
Open hemihepatectomy
Open approach was performed using a “J”-shaped or right 
subcostal incision with subxiphoid extension. After explo-
ration of the abdominal cavity and hemiliver mobilization, 
intraoperative ultrasound was performed. The hepatic hilum 
was encircled with a tourniquet to allow subsequent inter-
mittent Pringle maneuver. The ipsilateral hepatic artery and 
portal vein were then dissected and clamped in the hepatic 
hilum, delimiting the transection plane. CUSA® was used 
for parenchymal transection. The hemiliver pedicle was sec-
tioned between sutures and the suprahepatic vein using a 
vascular stapling device. An abdominal drain was routinely 
placed.
Definition of variables and outcomes
The main objective of the study was to assess clinical out-
comes and costs associated with LHH and OHH up to 
90 days postoperatively. Cases of LHH that resulted in 
conversion to open surgery were not censored and were 
included among the LHH group for all analyses based on 
intention-to-treat. The following patient-related variables 
were recorded: age, sex, body mass index (BMI), Ameri-
can Society of Anesthesiologists (ASA) class, and previ-
ous abdominal surgery (open or laparoscopic surgery or 
percutaneous radiofrequency ablation). Co-morbid condi-
tions were quantified according to the age-adjusted Charl-
son comorbidity index, which was calculated excluding 
liver tumor variables [13]. Liver-specific variables that 
were recorded included principle diagnosis and history of 
liver disease. Tumor-specific variables included the num-
ber, size, extent, and distribution of lesions and history 
of preoperative chemotherapy. Intraoperative variables 
included associated procedures (e.g., non-anatomical 
resection or radiofrequency ablation in the contralateral 
hemiliver), the use and duration of intermittent Pringle 
maneuver, operative time, blood loss, and reasons for 
conversion to open surgery in the LHH group. Surgical 
pathology was evaluated for tumor size and margins, with 
resection margins distancing  ≤ 1 mm from tumor cells 
classified as “R1”. Postoperative outcomes that were 
recorded included the need for blood transfusion, post-
operative intensive care stay, postoperative hospital stay, 
complications, re-interventions, unplanned readmissions, 
and mortality. All complications occurring up to 90 days 
postoperatively were recorded and graded according to 
the Clavien–Dindo [14] and Comprehensive Complica-
tion Index (CCI) systems, the latter of which computes 
all the complications a patient experiences in an index 
ranging from 0 to 100 [15]. Postoperative complications 
were categorized as surgical, medical, or liver specific. 
Liver-specific complications were classified according to 
the International Study Group for Liver Surgery (ISGLS) 
criteria. Bile leak was defined as a drain bilirubin concen-
tration > 3-times higher than the serum bilirubin concen-
tration at or beyond the third postoperative day and graded 
as A—requiring no change in patient’s clinical manage-
ment, B—requiring therapeutic intervention but manage-
able without surgical re-intervention, or C—requiring sur-
gical re-intervention [16]. Post-hepatectomy liver failure 
(PHLF) was defined as increased international normalized 
ratio (INR) and hyperbilirubinemia at or beyond the fifth 
postoperative day and graded as A—analytical deteriora-
tion not requiring any change in management, B—devia-
tion from regular postoperative clinical pathway managed 
without invasive treatment, or C—PHLF requiring an inva-
sive procedure [17]. Postoperative ascites was defined as 
drain fluid output > 10 mL/kg/day at or beyond the third 
postoperative day [18]. In addition to the hospital elec-
tronic medical record, the regional shared electronic medi-
cal record was checked for readmissions in other centers.
Costs
Intraoperative, postoperative, and readmission costs were 
obtained, including variable and fixed costs that were 
charged in each case. Intraoperative costs included con-
sumables (anesthetic drugs, transfusions, surgical instru-
mentation, and devices) and operating room and staff 
costs. Postoperative costs included pharmacy, transfusions, 
ICU and/or floor beds, studies and procedures (radiologi-
cal, endoscopic, and/or surgical), and other miscellaneous 
expenditures (laboratory, nursing, and other professional 
care). Readmission expenses including re-intervention 
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were grouped under total readmission costs. Taking into 
account the study inclusion period (2010–2018), costs 
were adjusted according to the mean annual inflation 
rate: 2010 + 1.8%, 2011 + 3.2, 2012 + 2.44, 2013 + 1.42, 
2014 − 0.15, 2015 − 0.5, 2016 − 0.2, 2017 + 2.97, 
2018 + 1.67 [19].
Data and statistical analysis
Categorical variables are described as frequencies and 
percentages and continuous variables as mean ± standard 
deviation or median (25–75% interquartile range). The 
propensity score method, which simulates the effects of 
a randomized trial for observational data, was used to 
estimate study outcomes. Inverse probability of treatment 
weighting (IPTW) of the propensity scores was used to 
create a pseudo-population in which study groups were 
balanced across covariates using data blinded to outcomes. 
Weights were derived using logistic regression to estimate 
average treatment effects in treated patients and stabilized 
by treatment prevalence. The following covariates were 
included in the propensity models: age, sex, ASA classi-
fication, BMI, age-adjusted Charlson comorbidity index, 
previous abdominal surgery, previous radiofrequency 
ablation, cirrhosis, indication for surgery, number of liver 
lesions, diameter of the largest lesion, number of affected 
liver segments, unilobar  versus  bilobar liver disease, 
preoperative chemotherapy and number of cycles, and 
planned additional procedure. Categorical variables were 
compared using the Chi-square test and continuous vari-
ables using ANOVA with rank-transformed data for both 
raw and IPTW-adjusted analyses. Covariate balance was 
assessed using the standardized difference, which is the 
difference between groups divided by the pooled standard 
deviation. Statistical significance was defined as p < 0.05. 
Statistical analyses were performed using SAS 9.4 (SAS 
Institute, Inc., Cary, North Carolina, USA).
Table 1  Patient, tumor, and surgical characteristics used for the propensity model
Descriptive statistics are frequencies (%) for categorical variables and median [25–75% interquartile range]. Bold marked figures are for p < 0.05
ASA American Society of Anesthesiologists, IPTW inverse probability of treatment weighting, LHH laparoscopic hemihepatectomy, OHH open 
hemihepatectomy
Raw analysis IPTW analysis
OHH (n = 96) LHH (n = 45) p value Standard-
ized differ-
ence
OHH LHH p value Standardized 
difference
Age (years) 65 [57–72] 65 [55–69] 0.476 − 0.120 65 [57–72] 67 [57–69] 0.889 0.028
Sex female 38 (40%) 23 (51%) 0.197 − 0.233 42 (45%) 16 (47%) 0.872 − 0.032
Body mass index 26 [23–28] 25 [23–28] 0.329 − 0.177 26 [23–27] 25 [23–28] 0.461 − 0.150
Age-adjusted Charlson comorbidity 
index
2 [1–4] 2 [1–3] 0.406 − 0.153 2 [2, 3] 2 [1–3] 0.669 − 0.087
ASA class
 I 4 (4%) 4 (9%) 0.258 0.192 4 (4%) 2 (5%) 0.872 0.032
 II 71 (74%) 34 (76%) 0.839 0.037 70 (76%) 27 (77%) 0.885 0.029
 III 21 (22%) 7 (16%) 0.380 − 0.163 19 (20%) 6 (18%) 0.810 − 0.048
Previous abdominal procedure 81 (84%) 38 (84%) 0.991 0.002 80 (86%) 30 (87%) 0.866 0.034
 Radiofrequency ablation 3 (3%) 0 0.230 − 0.254 2 (2%) 0 (0%) 0.378 − 0.212
 Open surgery 42 (44%) 9 (20%) 0.006 − 0.527 37 (39%) 10 (29%) 0.276 − 0.221
 Laparoscopic surgery 39 (41%) 29 (64%) 0.008 0.491 43 (46%) 20 (58%) 0.244 0.233
Cirrhosis 3 (3%) 2 (4%) 0.692 0.069 3 (3%) 1 (3%) 0.973 0.007
Malignant disease 89 (93%) 38 (84%) 0.126 0.262 85 (91%) 30 (87%) 0.455 0.142
Preoperative chemotherapy 44 (46%) 29 (64%) 0.039 0.381 49 (52%) 21 (61%) 0.374 0.178
Multiple lesions 49 (51%) 26 (58%) 0.454 0.136 52 (56%) 19 (55%) 0.890 − 0.027
Number of lesions 2 [1–4] 2 [1–3] 0.903 0.023 2 [1–4] 2 [1–4] 0.593 0.109
Number of affected segments 2 [1–3] 2 [2, 3] 0.587 0.100 2 [2, 3] 3 [2, 3] 0.643 0.095
Maximum diameter of lesions (mm) 33 [22–55] 27 [15–45] 0.114 − 0.283 33 [22–55] 32 [15–45] 0.436 − 0.155
Bilobar disease 26 (27%) 11 (24%) 0.739 − 0.060 23 (25%) 10 (29%) 0.683 0.080
Planned associated procedure 30 (31%) 10 (22%) 0.267 − 0.205 27 (29%) 9 (26%) 0.798 − 0.051
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Results
Between 01/2010 and 12/2018, 838 liver resections were 
performed at our center. Based on inclusion–exclusion cri-
teria, 141 were included for analysis: 96 OHH and 45 LHH 
(70% and 64% right hemihepatectomies, respectively).
Patient demographics and tumor and surgical 
characteristics
Baseline patient demographical information and tumor and 
surgical characteristics are listed in Table 1. The average 
patient in this study was around 65 years of age and over-
weight (BMI 25–26), with an ASA score of II. Men and 
women were equally represented among included patients. 
The indication for hemihepatectomy was malignant tumor 
in 90% of cases (OHH: 71% metastases, 22% primary liver 
tumors; LHH: 76% metastases, 9% primary liver tumors); 
consequentially, the majority of patients had a history of 
preoperative chemotherapy. In terms of tumor characteris-
tics, the median number was two lesions affecting ≥ 2 liver 
segments, and the median size of the largest lesion was 
approximately 3 cm. Approximately a quarter of patients 
presented bilobar disease that required an associated pro-
cedure in addition to hemihepatectomy. On raw analysis, a 
greater percentage of patients in the LHH group had previ-
ously received chemotherapy and undergone laparoscopic 
abdominal procedures as opposed to open ones. Following 
IPTW adjustments, covariates were balanced between 
the two groups, with all p values < 0.05 and standardized 
differences < 0.25.
Operative characteristics and intraoperative 
outcomes
Table 2 lists variables associated with the surgical inter-
ventions and intraoperative outcomes. Rates of any associ-
ated intraoperative procedure were similar between the two 
groups (29% OHH, 26% LHH, p = 0.798). However, when 
analyzing associated procedures individually, more patients 
in the LHH group underwent concomitant radiofrequency 
ablation (2% OHH, 14% LHH), while more patients in 
the OHH group underwent concomitant non-anatomical 
resection in the remnant hemiliver (24% OHH, 12% LHH, 
p = 0.010). As well, more patients in the LHH group were 
subjected to intermittent Pringle maneuver (44% OHH, 84% 
LHH, p < 0.001).
In the LHH group, approach was purely laparoscopic in 
35 cases (78%) and hybrid in 10 (22%). All hybrid cases 
were performed during the first 3 years of the study period. 
Among pure laparoscopic cases, conversion to open surgery 
was performed in six (17%): three for right upper quadrant 
adhesions, two for bleeding, and one for technical failure of 
the laparoscopic CUSA® device.
Operative times were significantly longer by 1 h in the 
LHH group (210 [180–255] minutes OHH, 270 [225–335] 
minutes LHH, p < 0.001), but LHH intraoperative blood 
Table 2  Operative variables and outcomes
Descriptive statistics are frequencies (%) for categorical variables and median [25–75% interquartile range]
IPTW inverse probability of treatment weighting, LHH laparoscopic hemihepatectomy, OHH open hemihepatectomy
a Calculated as a percentage of pure laparoscopic cases (n = 35)
b Failure of the laparoscopic CUSA®
Raw analysis IPTW analysis
OHH (n = 96) LHH (n = 45) p value OHH LHH p value
Right hepatectomy 67 (70%) 29 (64%) 0.526 72% 61% 0.237
Associated procedure (any) 30 (31%) 10 (22%) 0.268 29% 26% 0.798
 Non-anatomical resection 24 (25%) 5 (11%) 0.018 24% 12% 0.010
 Radiofrequency ablation 2 (2%) 5 (11%) 2% 14%
 Other 4 (4%) 0 3% 0
Pringle maneuver 42 (46%) 38 (86%)  < 0.001 44% 84%  < 0.001
Pringle maneuver (min) 18 [15–37] 33 [20–45] 0.028 17 [15–36] 30 [15–40] 0.081
Conversion to open  surgerya – 6 (17%) – – – –
 Bleeding – 2 (6%) – – – –
 Adhesions – 3 (9%) – – – –
 Technical  failureb – 1 (3%) – – – –
Operative time (min) 210 [180–255] 270 [225–340]  < 0.001 210 [180–255] 270 [225–335]  < 0.001
Blood loss (mL) 300 [200–500] 200 [100–300] 0.012 300 [150–500] 200 [50–300] 0.018
R1 resection 13 (14%) 5 (11%) 0.656 13 (14%) 4 (11%) 0.612
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Table 3  Postoperative complications and outcomes evaluated up to 90 days postoperatively
Descriptive statistics are frequencies (%) for categorical variables and mean ± standard deviation or median [25–75% interquartile range]
CCI Comprehensive Complication Index, ICU intensive care unit, IPTW inverse probability of treatment weighting, ISGLS International Study 
Group of Liver Surgery, PHLF post-hepatectomy liver failure, PRBC packed red blood cell, SD standard deviation
a CCI for entire group; for only patients that developed complications, CCI at discharge was 27.0 ± 12.2 OHH and 25.2 ± 20.8 LHH and at 
90 days 28.4 ± 12.0 OHH and 24.8 ± 18.8 LHH
b Does not include ISGLS PHLF Grade A
Raw analysis IPTW analysis
OHH (n = 96) LHH (n = 45) p value OHH LHH p value
At discharge
Overall complications 62 (65%) 19 (42%) 0.012 60% 39% 0.039
 Clavien–Dindo I/II 46 (48%) 15 (33%) 0.103 44% 29% 0.127
 Clavien–Dindo ≥ III 16 (17%) 4 (9%) 0.217 16% 10% 0.416
 CCIa 18.0 ± 16.2 10.7 ± 18.3 0.001 16.5 ± 16.1 9.7 ± 14.2 0.009
Overall postoperative stay (days) 8 [711] 6 [5–7]  < 0.001 8 [7–10] 6 [5–7]  < 0.001
ICU stay (days) 3 [1–4] 1 [0–3]  < 0.001 3 [1–4] 1 [0–2]  < 0.001
Blood transfusion 17 (18%) 1 (2%) 0.010 15% 1% 0.024
PRBC units 0.36 ± 0.92 0.04 ± 0.30 0.010 0.32 ± 0.87 0.02 ± 0.18 0.018
At 90 days
Liver-specific  complicationsb 16 (17%) 6 (13%) 0.611 16% 12% 0.600
 Bile leak (any) 9 (9%) 4 (9%) 0.926 9% 9% 0.948
  Grade A 2 (2%) 1 (2%) 0.396 2% 1% 0.610
  Grade B 5 (5%) 0 4% 0
  Grade C 2 (2%) 2 (4%) 3% 5%
 Ascites 5 (5%) 2 (4%) 0.846 5% 3% 0.685
 Encephalopathy 5 (5%) 0 0.119 4% 0 0.211
 ISGLS PHLF (any) 50 (52%) 13 (30%) 0.010 53% 34% 0.053
  Grade A 41 (43%) 12 (27%) 0.062 45% 32% 0.213
  Grade B 8 (8%) 1 (2%) 8% 2%
  Grade C 1 (1%) 0 1% 0
General complications 54 (56%) 14 (31%) 0.005 53% 28% 0.010
 Surgical complications 23 (24%) 5 (11%) 0.075 22% 12% 0.199
  Deep surgical site infection 11 (12%) 3 (7%) 0.375 10% 6% 0.546
  Intestinal obstruction 2 (2%) 1 (2%) 0.958 2% 4% 0.459
  Hemorrahge/hematoma 8 (8%) 0 0.046 7% 0 0.105
  Superficial surgical site infection 8 (8%) 1 (2%) 0.166 9% 2% 0.148
 Medical complications 37 (39%) 9 (20%) 0.029 37% 16% 0.022
  Arrhythmia 2 (2%) 0 0.330 2% 0 0.443
  Pneumonia 11 (12%) 1 (2%) 0.067 10% 1% 0.084
  Pleural effusion 6 (6%) 0 0.087 6% 0 0.134
  Paralytic ileus 12 (13%) 7 (16%) 0.620 11% 14% 0.688
  Urinary tract infection 6 (6%) 0 0.087 6% 0 0.140
  CVC infection 8 (8%) 0 0.046 7% 0 0.103
  Pulmonary embolism 2 (2%) 1 (2%) 0.958 3% 1% 0.477
Overall complications 71 (74%) 23 (51%) 0.007 69% 44% 0.010
 Clavien–Dindo I/II 48 (50%) 18 (40%) 0.267 46% 33% 0.189
 Clavien–Dindo ≥ III 23 (24%) 5 (11%) 0.075 23% 11% 0.130
 CCIa 21.6 ± 16.1 12.7 ± 18.3  < 0.001 20.0 ± 16.1 10.9 ± 14.2 0.001
Re-interventions at 90 days 6 (6%) 2 (4%) 0.666 6% 5% 0.758
Readmissions at 90 days 17 (18%) 3 (7%) 0.080 17% 4% 0.055
Mortality at 90 days 0 1 (2%) 0.143 0 1% 0.340
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loss was less (300 [150–500] mL OHH, 200 [50–300] mL 
LHH, p = 0.018). There were no differences in rates of “R1” 
resection (tumor cells ≤ 1 mm from the transection margin) 
detected between the two groups: 14% OHH and 11% LHH, 
p = 0.612.
Postoperative complications and outcomes
Postoperative complications and events are described in 
Table 3. Consequent to less intraoperative blood loss, fewer 
patients undergoing LHH received perioperative blood trans-
fusions (15% OHH, 1% LHH, p = 0.024). As well, fewer 
complications occurred in the LHH group prior to hospital 
discharge (overall 60% OHH, 39% LHH, p = 0.039), and 
CCI measured up to discharge was also lower with LHH 
(16.5 ± 16.1 OHH, 9.7 ± 14.2, p = 0.009). These differences 
were reflected in a reduction in ICU and overall postopera-
tive hospital stays for patients in the LHH vs. OHH groups 
by a median of 2 days for each (p < 0.001 in both cases).
By 90 days after surgery, overall complication rates 
were 69% OHH and 44% LHH (p = 0.01). Accordingly, 
CCI at 90 days was also lower with LHH (20.0 ± 16.1 
OHH, 10.9 ± 14.2 LHH, p = 0.001). Upon examination 
of the specific complications that arose during 90 days, 
liver-specific complications, including bile leak, ascites, 
encephalopathy, and PHLF requiring a change in patient 
management, occurred at similar rates following both 
OHH and LHH. Surgical complications also occurred 
at relatively similar rates, though there was a tendency 
toward more postoperative hemorrhage and superficial sur-
gical site infection among OHH patients. Medical compli-
cations, on the other hand, occurred at higher rates in the 
OHH group when compared with LHH (37% OHH, 16% 
LHH, p = 0.022). Medical complications were primarily 
pulmonary complications, including pneumonias and pleu-
ral effusions, and complications associated with the use 
of indwelling catheters, such as urinary tract infections 
and bloodstream infections arising from central venous 
catheters.
Rates of surgical re-intervention during the first 90 days 
did not differ between the OHH and LHH groups (6% and 
5%, respectively, p = 0.758). Six patients undergoing OHH 
were re-operated: two each for hemorrhage and bile leak 
during the index admission and another two for bowel 
obstruction on a subsequent readmission. Two patients 
undergoing LHH were re-operated laparoscopically for 
bile leak during the index admission.
There was a greater tendency toward readmissions 
among patients undergoing OHH as opposed to LHH (17% 
vs. 4%, respectively), though this difference did not reach 
the level statistical significance (p = 0.055). In terms of 
mortality, there was only one death prior to 90 days in 
Table 4  Cost analysis evaluated up to 90 days postoperatively
Values are reported in Euros (€) and presented as mean ± standard deviation or median [25–75% interquartile range]
a Laboratory tests and medical care during floor stay
Raw analysis IPTW analysis
OHH (n = 96) LHH (n = 45) p value OHH LHH % difference p value
Intraoperative costs
 Consumables 1801 [1468–2404] 3374 [2898–3889]  < 0.001 1777 [1429–2387] 3253 [2958–3889]  + 83  < 0.001
 OR time 1408 [1167–1748] 1827 [1452–2224]  < 0.001 1386 [1161–1745] 1730 [1393–2225]  + 29  < 0.001
 OR staff 821 [637–1262] 1290 [953–1551]  < 0.001 788 [632–1318] 1264 [902–1548]  + 60  < 0.001
 Total 4309 [3584–5348] 7239 [5542–8244]  < 0.001 4339 [3541–5346] 6917 [5314–8363]  + 59  < 0.001
Postoperative costs
 Pharmacy 184 [50–297] 100 [30–175] 0.067 163 [39–274] 100 [27–157] − 40 0.114
 Transfusions 90 ± 162 22 ± 111  < 0.001 80 ± 153 10 ± 67 − 88 0.001
 Postoperative stay 3896 [2603–4972] 2070 [1648–3313]  < 0.001 3574 [1978–4805] 2046 [1560–3012] − 43  < 0.001
  ICU 2379 [1121–3311] 797 [0–2212]  < 0.001 2212 [0–3188] 761 [0–1592] − 65  < 0.001
  Surgical floor 1492 [1183–1872] 1111 [857–1533]  < 0.001 1444 [1182–1850] 1182 [887–1560] − 18 0.002
 Techniques 142 [67–339] 87 [32–166] 0.008 124 [53–302] 60 [31–177] − 69 0.086
 Miscellaneousa 707 [501–1117] 515 [302–632]  < 0.001 651 [455–1075] 515 [294–580] − 21 0.002
 Total 4990 [3751–6434] 2924 [2079–4449]  < 0.001 4817 [2956–6251] 2875 [2066–4109] − 40  < 0.001
Total surgical 
admission costs
9916 [7766–12290] 10,448 [7703–
13730]
0.270 9254 [7134–11908] 10,396 [7540–
13730]
 + 12 0.195
Readmission costs 372 ± 1043 232 ± 1195 0.140 331 ± 944 110 ± 699 − 67 0.067




0.300 9936 [7134–11923] 10,448 [7703–
14240]
 + 5 0.286
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the entire cohort: a patient that underwent LHH died of 
massive pulmonary embolism during the first postopera-
tive week.
Costs
Perioperative costs are illustrated in Table 4. All operating 
room costs, including consumable material and costs associ-
ated with OR use and staffing, were higher for LHH versus 
OHH by a median of approximately 2500€ per procedure 
(p < 0.001). In contrast, postoperative costs, in particular 
those related to ICU and floor stays and medical staffing 
and care, were lower for LHH versus OHH by a median of 
roughly 2000€ per patient (p < 0.001). Costs for readmis-
sions in Table 4 are presented as the median for all patients 
included in each group; costs for only cases where read-
missions occurred were OHH (17 readmissions) 2049€ 
[1229–2411] and LHH 3 readmissions 1396€ [1229–4489], 
p = 1.0. Considering that median readmission costs were 
also reduced by about 200€ among LHH patients (a differ-
ence that did not reach statistical significance, p = 0.067), 
the overall balance of 90-day costs associated with OHH 
and LHH was similar: 9936€ [7134–11,908] and 10,448€ 
[7703–14,240], respectively, p = 0.286.
Discussion
In this study, we meticulously evaluated complications and 
costs associated with hemihepatectomy arising between 
index procedures up to 90 days postoperatively. The major 
findings were a relatively high rate of largely medical com-
plications following OHH that were concomitantly associ-
ated with increased ICU and overall postoperative hospital 
stays as well as higher postoperative costs relative to LHH. 
Readmission costs for OHH also tended to be higher. In 
contrast, upfront intraoperative costs associated with OHH 
were lower, and overall costs for the open and laparoscopic 
approaches to hemihepatectomy were equivalent after 3 
months of follow-up.
Previous studies following hemihepatectomy patients 
during their index hospitalization up to the end of the first 
postoperative month have also found relative cost equity 
when comparing open and laparoscopic procedures [8–10]. 
It has been determined for major surgical interventions, how-
ever, that limiting the period of observation to the end of the 
first postoperative month may overlook significant further 
morbidity, mortality, and costs, and a 90-day observation 
period appears to more accurately capture all relevant post-
operative events [11, 20–24]. In the present study, additional 
complications occurring beyond discharge were not negli-
gible, with approximately 10% more complications arising 
between discharge and 90 days among OHH patients and 5% 
more complications between discharge and 90 days among 
those undergoing LHH. Additional postoperative complica-
tions are not only relevant to patient satisfaction and quality 
of life but are also known to be a primary factor that serve to 
increase healthcare costs related to surgery [25, 26].
The overall rate of complications detected by 90 days 
in this study was ostensibly high: 69% for OHH and 44% 
for LHH. On the other hand, rates of moderate and severe 
complications requiring invasive therapy or management 
in intensive care (i.e., Clavien-Dindo III–V: 23% OHH and 
11% LHH) were relatively low in comparison with other 
recent studies examining outcomes following hemihepatec-
tomy [6–10]. Moreover, among patients developing compli-
cations, CCI, which provides a comprehensive view of all 
postoperative complications, with each graded according to 
its clinical impact (i.e., resources required to treat) remained 
below benchmark values in both groups, both at discharge 
(< 27.9) and at 3 months (< 32.6) [11].
Liver-specific complications were similar between the 
two groups in this study, though there was a tendency 
towards a higher rate of grade A PHLF (ongoing abnor-
mal laboratory values requiring no change in clinical man-
agement) following OHH. Rates of surgical complications 
(intraabdominal abscess/fluid collection, mechanical intes-
tinal obstruction, hemorrhage/hematoma, and superficial 
surgical site infection) were the same. However, rates of 
medical complications were significantly higher for OHH.
Medical complications not reaching the point of requir-
ing invasive and/or intensive care treatment may have been 
under-detected and/or -reported in previous retrospective 
studies evaluating outcomes following hemihepatectomy 
[6, 7, 10, 27]. We exhaustively evaluated all postoperative 
events, including delay in return of normal bowel function, 
which was surprisingly not improved among patients under-
going LHH. Manipulation of the bowel in both LHH and 
even OHH remains limited with respect to other intraab-
dominal procedures, yet hemihepatectomy can significantly 
impact bowel function based on the aggressive nature of the 
procedure itself, splanchnic congestion developing second-
ary to significant reduction in the size of the portal sinusoi-
dal bed, and a certain degree of portal hypertension devel-
oping in the postoperative period [28]. These events are the 
same regardless of the surgical approach. As well, due to 
inability to perform manual compression of the cut surface 
during transection, we frequently use the intermittent Pringle 
maneuver during laparoscopic hepatectomy to limit blood 
loss during parenchymal transection. For this reason, rates 
of utilization and overall length of hepatic hilar clamping 
were significantly greater for LHH than OHH. This, too, 
might have contributed to the 14% rate of postoperative par-
alytic ileus following LHH that we observed in our series. 
Given that return to normal bowel function is one of the key 
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endpoints in some prospective trials aiming to determine the 
impact of the laparoscopic approach on “functional recov-
ery” following surgery [29–31], this finding is noteworthy 
and a cause for reflection as to whether such an endpoint 
is the most appropriate to evaluate the benefits and impact 
of laparoscopy in the setting of this particular procedure or 
procedures of a similar nature.
Pulmonary complications are common following liver 
resection, arising in > 20% of cases in most series [32, 33]. 
A French multicenter study specifically focused on pulmo-
nary complications following major hepatic resection and 
detected a high rate for open procedures (41%) that was 
significantly reduced following laparoscopic procedures 
(13%) [34]. In this study, pulmonary complications (includ-
ing pneumonia, pleural effusion, and pulmonary embolism) 
were detected in 19% of patients following OHH but only 
2% of patients following LHH. Actual or perceived pain 
and other functional limitations associated with open inci-
sion and costal retraction in OHH contribute to suboptimal 
pulmonary hygiene in the postoperative period. Following 
laparoscopic and even hybrid hemihepatectomy; however, 
early abdominal wall pain and function are considerably 
improved, leading to better respiratory and earlier physical 
activity.
Medbery and colleagues introduced the concept of 
“value” into the armamentarium of the benefits offered by 
laparoscopic liver surgery—that quality (e.g., outcomes) can 
be improved while cutting costs [8]. Unlike the singular and 
largely nascent endpoints that are used in most surgical tri-
als, value takes into account not only perioperative events 
but also more remote outcome measures, such as physical 
recovery, ongoing pain, incisional hernias, disease recur-
rence, and survival. Given that the outcome benefits that 
laparoscopy offers may only be compounded over time, LHH 
appears to offer a value advantage over OHH. Furthermore, 
the value of LHH is likely to improve further still as sur-
gical expertise increases and upfront costs associated with 
the operative procedure progressively reduce due to shorter 
operative times and the ability to perform procedures with 
a more limited range of surgical instruments and devices. 
This is especially true for new generations of surgeons, who 
train directly in laparoscopy in other abdominal interven-
tions (e.g., cholecystectomies, appendectomies, colectomies) 
and will also train directly in laparoscopic hepatectomies 
using standardized techniques honed by their predecessors.
The present study does have limitations related to its 
retrospective nature and the non-randomized distribution 
of patients. Inverse probability of treatment weighting is a 
propensity method that does not remove patients but gives 
them distinct weights based on over- or underrepresenta-
tion of certain influential characteristics. Following IPTW 
adjustments, the results of this study continue to support 
the raw and unadjusted findings. Nonetheless, even IPTW 
adjustments cannot achieve the same balanced distribu-
tion of unquantified or unidentified variables as in a ran-
domized design [35]. Another limitation is the relatively 
small sample size, which is partially a consequence of 
increasing use of parenchymal-sparing surgical techniques, 
particularly for the resection of metastatic lesions [36]. As 
well, there is the fact that ten patients in the LHH group 
were operated using a hybrid approach. These patients 
belonged to the first 3 years of the inclusion period. It is 
important to note that all hybrid cases were planned preop-
eratively and were not unplanned conversions, which have 
been shown to be associated with greater perioperative 
morbidity and mortality [37]. Comparing the 35 pure lapa-
roscopic with the ten hybrid hemihepatectomies, both CCI 
at discharge and 90 days and costs at discharge and 90 days 
tended to be lower for the hybrid procedures, by and large 
based on the fact that intraoperative costs for the planned 
hybrid procedures were lower (7260€ [5723–7988] and 
4937€ [3473–6954], respectively, p = 0.024).
In summary, while laparoscopic hemihepatectomy 
remains a complex surgical procedure, it appears to offer 
considerable benefits over the open approach in terms of 
morbidity and costs arising postoperatively, not only dur-
ing index admission but also in subsequent readmissions. 
These savings in the postoperative period serve to off-
set the initial increase in operating room costs associated 
with laparoscopy. In the future, as experience with and 
results following minimally invasive liver surgery continue 
to improve, it is plausible that the laparoscopic or other 
minimally invasive approaches may eventually become the 
standard-of-care for hemihepatectomy as they already have 
for other more minor forms of liver resection.
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